Reflection paper on the Requirements for Selection …
Reflection paper on the Requirements for Selection and Justification of Starting Materials for the Manufacture of Chemical Active Substances EMA/CHMP/CVMP/QWP/826771/2016 Page 2/10
Download Reflection paper on the Requirements for Selection …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Graphite production further processing - Carbon …
www.carbonandgraphite.orgGeneral: The Graphitisation Process • The final step in the production of graphite is the graphitisation process. • Amorphous or baked carbon is converted to electrographite
CASSIA GUM Chemical and Technical Assessment …
www.fao.orgCassia gum (CTA) Page 1of 9 CASSIA GUM Chemical and Technical Assessment (CTA) Prepared by Professor Symon M. Mahungu and Mrs Inge Meyland 1. Summary
THE F C - Fitzpatrick
www.fitzmill.comhe Fitzpatrick Company is a manufacturer of stainless steel, sanitary process equipment, used by the Food, Chemical and Pharmaceutical Industries.
Ultra-High Shear Mixing Strategies
www.highshearmixers.comRoss White Paper: Ultra-High Shear Mixing Strategies Page 3 of 9 PreMax Batch Ultra-High Shear Mixer The Ross PreMax is a top-entering batch Ultra-High
Powder metallurgy – basics & applications
www.iitg.ac.inR. Ganesh Narayanan, IITG Mechanism of milling : Changes in the morphology of powder particles during milling results in the following events.
Proposed Syllabus For B.Tech Program in Chemical …
www.kanpuruniversity.orgSemester-V L T P Cr CHE-S301 Transport Processes & Unit Operation-IV 3 1 0 4 (Mass Transfer-I) CHE-S302 Chemical Process Industries-II 3 1 0 4